25 XP   0   0   10

Olema Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Olema together

PenkeI guess you are interested in Olema Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Olema Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Olema Pharmaceuticals Inc

I send you an email if I find something interesting about Olema Pharmaceuticals Inc.

Quick analysis of Olema (30 sec.)










What can you expect buying and holding a share of Olema? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.54
Expected worth in 1 year
$5.55
How sure are you?
17.6%

+ What do you gain per year?

Total Gains per Share
$1.01
Return On Investment
9.0%

For what price can you sell your share?

Current Price per Share
$11.20
Expected price per share
$10.65 - $16.78
How sure are you?
50%

1. Valuation of Olema (5 min.)




Live pricePrice per Share (EOD)

$11.20

Intrinsic Value Per Share

$-17.64 - $-20.68

Total Value Per Share

$-13.10 - $-16.14

2. Growth of Olema (5 min.)




Is Olema growing?

Current yearPrevious yearGrowGrow %
How rich?$253.8m$229.1m-$12.7m-5.9%

How much money is Olema making?

Current yearPrevious yearGrowGrow %
Making money-$23.8m-$25.6m$1.8m7.6%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Olema (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#209 / 1031

Most Revenue
#726 / 1031

Most Profit
#772 / 1031

Most Efficient
#175 / 1031

What can you expect buying and holding a share of Olema? (5 min.)

Welcome investor! Olema's management wants to use your money to grow the business. In return you get a share of Olema.

What can you expect buying and holding a share of Olema?

First you should know what it really means to hold a share of Olema. And how you can make/lose money.

Speculation

The Price per Share of Olema is $11.20. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Olema.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Olema, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.54. Based on the TTM, the Book Value Change Per Share is $0.25 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Olema.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.48-4.3%-0.43-3.9%-0.47-4.2%-0.31-2.8%-0.31-2.8%
Usd Book Value Change Per Share-0.38-3.4%0.252.2%-0.39-3.5%0.272.4%0.272.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.38-3.4%0.252.2%-0.39-3.5%0.272.4%0.272.4%
Usd Price Per Share14.03-9.72-3.39-11.68-11.68-
Price to Earnings Ratio-7.33--5.84--1.83--10.52--10.52-
Price-to-Total Gains Ratio-36.94--19.29--8.81--40.99--40.99-
Price to Book Ratio3.09-2.46-0.82-2.28-2.28-
Price-to-Total Gains Ratio-36.94--19.29--8.81--40.99--40.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.2
Number of shares89
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.250.27
Usd Total Gains Per Share0.250.27
Gains per Quarter (89 shares)22.4223.77
Gains per Year (89 shares)89.6995.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10908009585
201791700190180
302692600285275
403593500380370
504484400475465
605385300571560
706286200666655
807187100761750
908078000856845
1008978900951940

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%3.012.02.017.6%3.012.02.017.6%3.012.02.017.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%3.012.02.017.6%3.012.02.017.6%3.012.02.017.6%

Fundamentals of Olema

About Olema Pharmaceuticals Inc

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; and OP-1250 combine with CDK4/6 inhibitors palbociclib, ribociclib, and alpelisib in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive human epidermal growth factor receptor 2-negative breast cancer, as well as develops OPERA-01 for the of ER+/HER2- advanced or metastatic breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Fundamental data was last updated by Penke on 2024-03-21 02:03:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Olema Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Olema earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Olema to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Olema Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--171.8%+171.8%
TTM--205.8%+205.8%
YOY--262.1%+262.1%
5Y--455.6%+455.6%
10Y--589.0%+589.0%
1.1.2. Return on Assets

Shows how efficient Olema is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Olema to the Biotechnology industry mean.
  • -9.7% Return on Assets means that Olema generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Olema Pharmaceuticals Inc:

  • The MRQ is -9.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.7%TTM-10.5%+0.9%
TTM-10.5%YOY-10.6%+0.1%
TTM-10.5%5Y-236.9%+226.4%
5Y-236.9%10Y-236.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.7%-12.5%+2.8%
TTM-10.5%-12.2%+1.7%
YOY-10.6%-11.2%+0.6%
5Y-236.9%-13.4%-223.5%
10Y-236.9%-14.7%-222.2%
1.1.3. Return on Equity

Shows how efficient Olema is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Olema to the Biotechnology industry mean.
  • -10.5% Return on Equity means Olema generated $-0.11 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Olema Pharmaceuticals Inc:

  • The MRQ is -10.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.5%TTM-11.6%+1.0%
TTM-11.6%YOY-11.3%-0.2%
TTM-11.6%5Y-7.3%-4.3%
5Y-7.3%10Y-7.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.5%-15.8%+5.3%
TTM-11.6%-15.7%+4.1%
YOY-11.3%-13.9%+2.6%
5Y-7.3%-18.3%+11.0%
10Y-7.3%-19.2%+11.9%

1.2. Operating Efficiency of Olema Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Olema is operating .

  • Measures how much profit Olema makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Olema to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Olema Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM--210.1%+210.1%
YOY--279.7%+279.7%
5Y--459.9%+459.9%
10Y--596.9%+596.9%
1.2.2. Operating Ratio

Measures how efficient Olema is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Olema Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.861-2.861
TTM-3.193-3.193
YOY-3.615-3.615
5Y-5.560-5.560
10Y-7.396-7.396

1.3. Liquidity of Olema Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Olema is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 12.33 means the company has $12.33 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Olema Pharmaceuticals Inc:

  • The MRQ is 12.327. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.828. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.327TTM12.828-0.501
TTM12.828YOY19.218-6.390
TTM12.8285Y23.283-10.456
5Y23.28310Y23.2830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.3273.986+8.341
TTM12.8284.440+8.388
YOY19.2185.552+13.666
5Y23.2836.158+17.125
10Y23.2836.492+16.791
1.3.2. Quick Ratio

Measures if Olema is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Olema to the Biotechnology industry mean.
  • A Quick Ratio of 21.08 means the company can pay off $21.08 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Olema Pharmaceuticals Inc:

  • The MRQ is 21.079. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 21.448. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ21.079TTM21.448-0.369
TTM21.448YOY36.089-14.641
TTM21.4485Y37.828-16.381
5Y37.82810Y37.8280.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ21.0793.638+17.441
TTM21.4484.168+17.280
YOY36.0895.515+30.574
5Y37.8286.012+31.816
10Y37.8286.209+31.619

1.4. Solvency of Olema Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Olema assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Olema to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.08 means that Olema assets are financed with 8.3% credit (debt) and the remaining percentage (100% - 8.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Olema Pharmaceuticals Inc:

  • The MRQ is 0.083. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.085. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.083TTM0.085-0.002
TTM0.085YOY0.062+0.023
TTM0.0855Y14.384-14.299
5Y14.38410Y14.3840.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0830.335-0.252
TTM0.0850.330-0.245
YOY0.0620.267-0.205
5Y14.3840.367+14.017
10Y14.3840.378+14.006
1.4.2. Debt to Equity Ratio

Measures if Olema is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Olema to the Biotechnology industry mean.
  • A Debt to Equity ratio of 9.1% means that company has $0.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Olema Pharmaceuticals Inc:

  • The MRQ is 0.091. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.093. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.091TTM0.093-0.002
TTM0.093YOY0.066+0.027
TTM0.0935Y0.047+0.046
5Y0.04710Y0.0470.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0910.376-0.285
TTM0.0930.398-0.305
YOY0.0660.334-0.268
5Y0.0470.429-0.382
10Y0.0470.476-0.429

2. Market Valuation of Olema Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Olema generates.

  • Above 15 is considered overpriced but always compare Olema to the Biotechnology industry mean.
  • A PE ratio of -7.33 means the investor is paying $-7.33 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Olema Pharmaceuticals Inc:

  • The EOD is -5.848. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.326. Based on the earnings, the company is expensive. -2
  • The TTM is -5.838. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.848MRQ-7.326+1.478
MRQ-7.326TTM-5.838-1.488
TTM-5.838YOY-1.831-4.007
TTM-5.8385Y-10.523+4.685
5Y-10.52310Y-10.5230.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.848-2.643-3.205
MRQ-7.326-2.418-4.908
TTM-5.838-2.742-3.096
YOY-1.831-4.123+2.292
5Y-10.523-6.257-4.266
10Y-10.523-6.478-4.045
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Olema Pharmaceuticals Inc:

  • The EOD is -8.474. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.615. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.573. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.474MRQ-10.615+2.141
MRQ-10.615TTM-6.573-4.042
TTM-6.573YOY-2.330-4.243
TTM-6.5735Y-13.569+6.996
5Y-13.56910Y-13.5690.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.474-3.244-5.230
MRQ-10.615-2.939-7.676
TTM-6.573-3.478-3.095
YOY-2.330-5.592+3.262
5Y-13.569-8.473-5.096
10Y-13.569-8.881-4.688
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Olema is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.09 means the investor is paying $3.09 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Olema Pharmaceuticals Inc:

  • The EOD is 2.467. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.090. Based on the equity, the company is fair priced.
  • The TTM is 2.458. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.467MRQ3.090-0.623
MRQ3.090TTM2.458+0.631
TTM2.458YOY0.816+1.642
TTM2.4585Y2.275+0.183
5Y2.27510Y2.2750.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.4672.124+0.343
MRQ3.0902.041+1.049
TTM2.4582.118+0.340
YOY0.8162.915-2.099
5Y2.2753.682-1.407
10Y2.2754.114-1.839
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Olema Pharmaceuticals Inc.

3.1. Institutions holding Olema Pharmaceuticals Inc

Institutions are holding 93.547% of the shares of Olema Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Bvf Inc16.58143.04259135893152439020.0275
2023-12-31Paradigm Biocapital Advisors LP14.34495.191579036001000001.2815
2023-12-31Logos Global Management LP7.95665.0758438387564000017.0946
2023-12-31BlackRock Inc5.92390.00123263907102101845.5224
2023-12-31Vanguard Group Inc4.91110.0008270589599558858.2111
2023-12-31Cormorant Asset Management, LLC4.4591.64622456800-2047964-45.4622
2023-12-31Deep Track Capital, LP3.50450.9047193089400
2023-12-31Vivo Capital, LLC3.40072.1524187370400
2023-12-31MPM Oncology Impact Management LP3.37076.09591857136-545-0.0293
2023-12-31Dimensional Fund Advisors, Inc.3.11340.0071715420214201.2645
2023-12-31Geode Capital Management, LLC1.49710.001282483316907925.7839
2023-12-31Woodline Partners LP1.36170.1145750279329474.593
2023-12-31Polar Capital Holdings PLC1.36120.064575000000
2023-12-31HHG PLC1.27070.00597001007001000
2023-12-31State Street Corporation1.22180.000567317011405320.3988
2023-12-31Ally Bridge Group (NY) LLC1.19615.50946590356590350
2023-12-31First Light Asset Management, LLC1.14540.71236310646310640
2023-12-31Goldman Sachs Group Inc1.14520.0008630956537021571.6943
2023-12-31Victory Capital Management Inc.1.12810.0092621527558077879.554
2023-12-31SILVERARC CAPITAL MANAGEMENT, LLC1.04152.396457383016602940.7132
Total 79.93532.932744041918+5821312+13.2%

3.2. Funds holding Olema Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Vanguard Total Stock Mkt Idx Inv2.99530.0015165032600
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr1.42330.0106784172-10998-1.3831
2024-01-31Polar Capital Biotech S Inc1.36120.60175000000
2024-02-29iShares Russell 2000 ETF1.18220.013651365-106-0.0163
2024-01-31DFA US Targeted Value I0.78910.04443474800
2024-02-29iShares Biotechnology ETF0.66280.0595365185-1645-0.4484
2023-12-31Victory Science & Technology0.57530.399331695811618957.872
2024-01-31DFA US Small Cap I0.51860.025328574200
2024-01-31Fidelity Extended Market Index0.51570.010428416129311.0422
2023-12-31Fidelity Small Cap Index0.48760.014826867541091.5531
2024-01-31DFA US Micro Cap I0.46420.04925576000
2024-02-01iShares Russell 2000 Value ETF0.45290.03222495113160.1268
2023-12-31Candriam Global Equities Oncology0.39020.16252150002150000
2024-01-31Belfius Equities Cure C Cap0.39020.152521500000
2024-02-29Bridge Builder Small/Mid Cap Growth0.36730.0303202389-36976-15.4475
2023-12-31Victory RS Small Cap Growth CIT N0.32990.46121817801817800
2023-12-31Victory RS Small Cap Growth A0.32990.46141817801817800
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.31430.0051173172109006.7171
2024-01-31Columbia Small Cap Value I A0.3070.168116914012000.7145
2023-12-31Columbia Small Cap Value I0.30480.1726167940-55780-24.933
Total 14.16182.87437802804+608700+7.8%

3.3. Insider Transactions

Insiders are holding 3.948% of the shares of Olema Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-29Cyrus HarmonSELL2500012.41
2024-01-31Cyrus HarmonSELL2500012.23
2023-12-06Biocapital Advisors L ParadigmBUY10000011.6
2023-12-05G. Walmsley GrahamBUY13187014.19
2023-11-30Cyrus HarmonSELL2500012.57
2023-11-21Cyrus HarmonSELL419214.86
2023-11-21Naseem ZojwallaSELL746114.84
2023-11-21Sean BohenSELL2929314.88
2023-11-08David C MylesSELL20017.61
2023-11-03David C MylesSELL54117.51
2023-11-02Cyrus HarmonSELL500015.64
2023-11-01David C MylesSELL666815.02
2023-10-31Cyrus HarmonSELL2500012.05
2023-09-29Cyrus HarmonSELL2500012.41
2023-09-19David C MylesSELL2000012.67
2023-09-12Bvf Partners L P/ilBUY15059329.84
2023-09-05Cyrus HarmonSELL1000011.62
2023-08-31Cyrus HarmonSELL150009.36
2023-06-08Cyrus HarmonSELL100006.3
2023-06-05Cyrus HarmonSELL50006.04

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Olema Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.3800.252-251%-0.389+2%0.267-242%0.267-242%
Book Value Per Share--4.5413.870+17%4.098+11%3.618+25%3.618+25%
Current Ratio--12.32712.828-4%19.218-36%23.283-47%23.283-47%
Debt To Asset Ratio--0.0830.085-2%0.062+35%14.384-99%14.384-99%
Debt To Equity Ratio--0.0910.093-3%0.066+37%0.047+92%0.047+92%
Dividend Per Share----0%-0%-0%-0%
Eps---0.479-0.432-10%-0.469-2%-0.311-35%-0.311-35%
Free Cash Flow Per Share---0.330-0.374+13%-0.369+12%-0.252-24%-0.252-24%
Free Cash Flow To Equity Per Share---0.3210.222-245%-0.366+14%0.730-144%0.730-144%
Gross Profit Margin--1.0031.001+0%1.000+0%1.000+0%1.000+0%
Intrinsic Value_10Y_max---20.677--------
Intrinsic Value_10Y_min---17.636--------
Intrinsic Value_1Y_max---1.416--------
Intrinsic Value_1Y_min---1.390--------
Intrinsic Value_3Y_max---4.753--------
Intrinsic Value_3Y_min---4.528--------
Intrinsic Value_5Y_max---8.694--------
Intrinsic Value_5Y_min---8.027--------
Market Cap626244640.000-25%784483241.000543490884.000+44%189271259.500+314%653149478.000+20%653149478.000+20%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio2.467-25%3.0902.458+26%0.816+279%2.275+36%2.275+36%
Pe Ratio-5.848+20%-7.326-5.838-20%-1.831-75%-10.523+44%-10.523+44%
Price Per Share11.200-25%14.0309.720+44%3.385+314%11.681+20%11.681+20%
Price To Free Cash Flow Ratio-8.474+20%-10.615-6.573-38%-2.330-78%-13.569+28%-13.569+28%
Price To Total Gains Ratio-29.486+20%-36.936-19.288-48%-8.808-76%-40.987+11%-40.987+11%
Quick Ratio--21.07921.448-2%36.089-42%37.828-44%37.828-44%
Return On Assets---0.097-0.105+9%-0.106+10%-2.369+2351%-2.369+2351%
Return On Equity---0.105-0.116+10%-0.113+7%-0.073-31%-0.073-31%
Total Gains Per Share---0.3800.252-251%-0.389+2%0.267-242%0.267-242%
Usd Book Value--253895000.000216396750.000+17%229154500.000+11%202325941.176+25%202325941.176+25%
Usd Book Value Change Per Share---0.3800.252-251%-0.389+2%0.267-242%0.267-242%
Usd Book Value Per Share--4.5413.870+17%4.098+11%3.618+25%3.618+25%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.479-0.432-10%-0.469-2%-0.311-35%-0.311-35%
Usd Free Cash Flow---18476000.000-20931750.000+13%-20607000.000+12%-14070000.000-24%-14070000.000-24%
Usd Free Cash Flow Per Share---0.330-0.374+13%-0.369+12%-0.252-24%-0.252-24%
Usd Free Cash Flow To Equity Per Share---0.3210.222-245%-0.366+14%0.730-144%0.730-144%
Usd Market Cap626244640.000-25%784483241.000543490884.000+44%189271259.500+314%653149478.000+20%653149478.000+20%
Usd Price Per Share11.200-25%14.0309.720+44%3.385+314%11.681+20%11.681+20%
Usd Profit---26772000.000-23834750.000-11%-25646500.000-4%-17185823.529-36%-17185823.529-36%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.3800.252-251%-0.389+2%0.267-242%0.267-242%
 EOD+3 -5MRQTTM+16 -14YOY+20 -105Y+10 -2010Y+10 -20

4.2. Fundamental Score

Let's check the fundamental score of Olema Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.848
Price to Book Ratio (EOD)Between0-12.467
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than121.079
Current Ratio (MRQ)Greater than112.327
Debt to Asset Ratio (MRQ)Less than10.083
Debt to Equity Ratio (MRQ)Less than10.091
Return on Equity (MRQ)Greater than0.15-0.105
Return on Assets (MRQ)Greater than0.05-0.097
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Olema Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.422
Ma 20Greater thanMa 5012.395
Ma 50Greater thanMa 10013.090
Ma 100Greater thanMa 20013.448
OpenGreater thanClose11.010
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -1,813835-978460-518277-241588347



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets276,945
Total Liabilities23,050
Total Stockholder Equity253,895
 As reported
Total Liabilities 23,050
Total Stockholder Equity+ 253,895
Total Assets = 276,945

Assets

Total Assets276,945
Total Current Assets266,513
Long-term Assets10,432
Total Current Assets
Cash And Cash Equivalents 68,539
Short-term Investments 193,268
Net Receivables 673
Other Current Assets 4,033
Total Current Assets  (as reported)266,513
Total Current Assets  (calculated)266,513
+/-0
Long-term Assets
Property Plant Equipment 3,259
Other Assets 0
Long-term Assets  (as reported)10,432
Long-term Assets  (calculated)3,259
+/- 7,173

Liabilities & Shareholders' Equity

Total Current Liabilities21,621
Long-term Liabilities1,429
Total Stockholder Equity253,895
Total Current Liabilities
Short-term Debt 988
Accounts payable 2,698
Other Current Liabilities 17,935
Total Current Liabilities  (as reported)21,621
Total Current Liabilities  (calculated)21,621
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,429
Long-term Liabilities  (as reported)1,429
Long-term Liabilities  (calculated)1,429
+/-0
Total Stockholder Equity
Common Stock4
Retained Earnings -305,632
Accumulated Other Comprehensive Income 347
Other Stockholders Equity 559,176
Total Stockholder Equity (as reported)253,895
Total Stockholder Equity (calculated)253,895
+/-0
Other
Capital Stock4
Cash and Short Term Investments 261,807
Common Stock Shares Outstanding 54,784
Liabilities and Stockholders Equity 276,945
Net Debt -66,122
Net Invested Capital 253,895
Net Working Capital 244,892
Property Plant and Equipment Gross 3,259
Short Long Term Debt Total 2,417



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
> Total Assets 
132
0
0
130,683
342,722
331,301
322,230
309,795
295,945
277,418
250,600
231,997
215,645
195,768
177,624
292,799
276,945
276,945292,799177,624195,768215,645231,997250,600277,418295,945309,795322,230331,301342,722130,68300132
   > Total Current Assets 
103
0
0
129,087
342,137
330,265
320,854
308,280
287,250
270,214
243,026
225,058
208,899
189,397
171,509
282,008
266,513
266,513282,008171,509189,397208,899225,058243,026270,214287,250308,280320,854330,265342,137129,08700103
       Cash And Cash Equivalents 
68
0
0
127,824
338,549
47,881
50,422
25,597
287,250
21,509
24,526
26,804
23,702
40,918
34,958
117,407
68,539
68,539117,40734,95840,91823,70226,80424,52621,509287,25025,59750,42247,881338,549127,8240068
       Short-term Investments 
0
0
0
0
0
279,087
267,722
280,357
273,438
246,358
216,185
195,796
180,719
145,036
132,486
159,494
193,268
193,268159,494132,486145,036180,719195,796216,185246,358273,438280,357267,722279,08700000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
457
319
302
622
740
673
67374062230231945700000000000
       Other Current Assets 
35
0
0
328
149
481
184
233
223
467
451
78
4,478
3,443
237
274
4,033
4,0332742373,4434,478784514672232331844811493280035
   > Long-term Assets 
29
0
0
1,596
585
1,036
1,376
1,515
8,695
7,204
7,574
6,939
6,746
6,371
6,115
10,791
10,432
10,43210,7916,1156,3716,7466,9397,5747,2048,6951,5151,3761,0365851,5960029
       Property Plant Equipment 
26
0
0
24
75
526
866
975
4,720
4,410
4,478
4,168
3,975
3,600
3,211
3,614
3,259
3,2593,6143,2113,6003,9754,1684,4784,4104,72097586652675240026
       Other Assets 
3
0
0
0
510
510
4,086
540
540
2,794
3,096
0
2,771
0
10,180
0
0
0010,18002,77103,0962,7945405404,0865105100003
> Total Liabilities 
10,726
0
0
5,273
4,585
5,277
8,146
8,901
11,376
12,328
14,317
14,298
18,099
20,793
16,041
17,665
23,050
23,05017,66516,04120,79318,09914,29814,31712,32811,3768,9018,1465,2774,5855,2730010,726
   > Total Current Liabilities 
1,378
0
0
5,273
4,585
5,277
8,146
8,901
9,019
10,168
12,308
12,552
16,549
19,410
14,831
15,966
21,621
21,62115,96614,83119,41016,54912,55212,30810,1689,0198,9018,1465,2774,5855,273001,378
       Short-term Debt 
0
0
0
0
0
0
0
0
931
881
1,078
1,084
1,015
908
798
924
988
9889247989081,0151,0841,07888193100000000
       Accounts payable 
935
0
0
97
719
419
385
306
23
268
120
14
374
681
1,625
2,207
2,698
2,6982,2071,62568137414120268233063854197199700935
       Other Current Liabilities 
443
0
0
5,176
3,866
4,858
7,761
8,595
378
9,019
11,110
11,454
15,160
17,821
21
12,835
17,935
17,93512,8352117,82115,16011,45411,1109,0193788,5957,7614,8583,8665,17600443
   > Long-term Liabilities 
9,348
0
0
0
0
0
0
0
2,357
2,160
2,009
1,746
1,550
1,383
1,210
1,699
1,429
1,4291,6991,2101,3831,5501,7462,0092,1602,35700000009,348
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,210
0
0
001,21000000000000000
> Total Stockholder Equity
-10,594
0
0
125,410
338,137
326,024
314,084
300,894
284,569
265,090
236,283
217,699
197,546
174,975
161,583
275,134
253,895
253,895275,134161,583174,975197,546217,699236,283265,090284,569300,894314,084326,024338,137125,41000-10,594
   Common Stock
1
0
0
3
3
3
3
3
3
3
3
3
3
3
3
4
4
44333333333333001
   Retained Earnings -305,632-278,860-257,358-237,263-208,977-182,798-160,078-127,220-104,190-82,552-64,839-48,433-33,094-22,96300-10,762
   Accumulated Other Comprehensive Income 
-80
0
0
-87
0
-13
-14
15
-149
-1,626
-2,398
-2,674
-1,813
-978
-518
-241
347
347-241-518-978-1,813-2,674-2,398-1,626-14915-14-130-8700-80
   Capital Surplus 
0
0
0
0
0
374,467
378,934
383,428
388,904
393,933
398,756
403,168
408,333
413,213
419,456
0
0
00419,456413,213408,333403,168398,756393,933388,904383,428378,934374,46700000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
248
0
0
148,457
371,228
374,467
378,934
383,428
388,904
393,933
398,756
403,168
408,333
413,213
419,456
554,231
559,176
559,176554,231419,456413,213408,333403,168398,756393,933388,904383,428378,934374,467371,228148,45700248



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-377
Gross Profit-377-377
 
Operating Income (+$)
Gross Profit-377
Operating Expense-104,584
Operating Income-104,961-104,961
 
Operating Expense (+$)
Research Development86,140
Selling General Administrative18,821
Selling And Marketing Expenses377
Operating Expense104,584105,338
 
Net Interest Income (+$)
Interest Income5,747
Interest Expense-0
Other Finance Cost-0
Net Interest Income5,747
 
Pretax Income (+$)
Operating Income-104,961
Net Interest Income5,747
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-96,655-113,267
EBIT - interestExpense = -104,961
-96,655
-96,655
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-104,961-96,655
Earnings Before Interest and Taxes (EBITDA)-104,584
 
After tax Income (+$)
Income Before Tax-96,655
Tax Provision-0
Net Income From Continuing Ops-96,062-96,655
Net Income-96,655
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses104,961
Total Other Income/Expenses Net8,306-5,747
 

Technical Analysis of Olema
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Olema. The general trend of Olema is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Olema's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Olema Pharmaceuticals Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 11.94 < 15.32 < 16.78.

The bearish price targets are: 10.84 > 10.82 > 10.65.

Tweet this
Olema Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Olema Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Olema Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Olema Pharmaceuticals Inc. The current macd is -0.70946452.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Olema price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Olema. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Olema price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Olema Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartOlema Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Olema Pharmaceuticals Inc. The current adx is 27.54.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Olema shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Olema Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Olema Pharmaceuticals Inc. The current sar is 13.06.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Olema Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Olema Pharmaceuticals Inc. The current rsi is 38.42. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Olema Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartOlema Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Olema Pharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Olema price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Olema Pharmaceuticals Inc Daily Stochastic Oscillator ChartOlema Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Olema Pharmaceuticals Inc. The current cci is -77.83123371.

Olema Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartOlema Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Olema Pharmaceuticals Inc. The current cmo is -27.43029619.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Olema Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartOlema Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Olema Pharmaceuticals Inc. The current willr is -85.48812665.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Olema Pharmaceuticals Inc Daily Williams %R ChartOlema Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Olema Pharmaceuticals Inc.

Olema Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Olema Pharmaceuticals Inc. The current atr is 0.93365047.

Olema Pharmaceuticals Inc Daily Average True Range (ATR) ChartOlema Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Olema Pharmaceuticals Inc. The current obv is 3,106,313.

Olema Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartOlema Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Olema Pharmaceuticals Inc. The current mfi is 29.00.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Olema Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartOlema Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Olema Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Olema Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Olema Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.422
Ma 20Greater thanMa 5012.395
Ma 50Greater thanMa 10013.090
Ma 100Greater thanMa 20013.448
OpenGreater thanClose11.010
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Olema with someone you think should read this too:
  • Are you bullish or bearish on Olema? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Olema? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Olema Pharmaceuticals Inc

I send you an email if I find something interesting about Olema Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Olema Pharmaceuticals Inc.

Receive notifications about Olema Pharmaceuticals Inc in your mailbox!